Atlas Trials

Phase IIa Dose-Expansion and Biomarker Study of OPB-111077

Clinical trial NCT03158324 · UNKNOWN

Trial details

NCT number
NCT03158324
Sponsor
National University Hospital, Singapore
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
NPCRefractory Tumor
Start date
2017-05-22
Primary completion
2020-05-22
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.